Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q3 2025

Type / Class
Equity / Ordinary Shares, par value $0.0001 per share
Symbol
CORBF on OTC
Shares outstanding
133,765,508
Price per share
$1.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
13,527
Total reported value
$13,660
% of total 13F portfolios
0%
Share change
-11,455
Value change
-$11,569
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Oasis Management Co Ltd. 13% 17,389,516 Oasis Management Company Ltd 31 Mar 2025

As of 30 Sep 2025, 2 institutional investors reported holding 13,527 shares of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF). This represents 0.01% of the company’s total 133,765,508 outstanding shares.

Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 13,527 $13,660 -$11,569 $1.00 2
2025 Q2 24,982 $37,464 $1.47 2
2025 Q1 24,982 $22,492 -$17,946 $0.93 2
2024 Q4 44,922 $67,383 $1.50 2
2024 Q3 44,757 $78,324 $1.75 1
2024 Q2 44,757 $51,470 -$9,397 $1.15 1
2024 Q1 52,894 $71,405 $1.35 2
2023 Q4 52,894 $64,529 +$9,683 $1.22 2
2023 Q3 44,957 $55,746 -$228,284 $1.24 2
2023 Q2 262,331 $275,488 -$29,051,041 $1.05 6
2023 Q1 9,944,716 $29,711,425 -$816,969 $2.99 19
2022 Q4 10,230,806 $30,560,206 -$1,109,740 $2.99 20
2022 Q3 12,948,607 $38,684,458 +$3,742,306 $2.99 20
2022 Q2 11,720,823 $34,694,000 +$188,969 $2.96 24
2022 Q1 11,049,025 $42,536,000 +$980,387 $3.85 25
2021 Q4 10,768,414 $45,118,000 +$1,560,892 $4.19 27
2021 Q3 10,205,400 $47,664,000 -$8,840,870 $4.67 25
2021 Q2 12,059,576 $64,399,000 +$17,842,422 $5.34 29
2021 Q1 8,739,671 $39,589,359 +$7,479,979 $4.53 31
2020 Q4 7,234,906 $26,839,510 -$1,325,690 $3.71 25
2020 Q3 7,596,426 $26,890,000 +$286,340 $3.54 25
2020 Q2 7,564,218 $23,449,000 +$1,994,611 $3.10 28
2020 Q1 6,921,256 $22,009,000 -$1,347,955 $3.18 29
2019 Q4 19,269,439 $96,346,000 -$5,991,843 $5.00 33
2019 Q3 20,476,364 $99,102,000 -$6,266,748 $4.84 41
2019 Q2 21,445,520 $123,954,000 -$565,189 $5.78 38
2019 Q1 21,531,574 $151,136,000 +$98,457,075 $7.02 36
2018 Q4 7,519,944 $48,501,000 -$227,089 $6.45 36
2018 Q3 7,514,835 $52,523,579 -$8,156,713 $6.99 41
2018 Q2 8,500,232 $80,672,079 -$10,763,522 $9.49 45
2018 Q1 9,621,427 $98,134,703 +$91,672,709 $10.20 57